KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EBT: 2017-2025

Historic EBT for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to -$77.0 million.

  • Twist Bioscience's EBT rose 22.65% to -$26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.0 million, marking a year-over-year increase of 63.03%. This contributed to the annual value of -$77.0 million for FY2025, which is 63.03% up from last year.
  • Latest data reveals that Twist Bioscience reported EBT of -$77.0 million as of FY2025, which was up 63.03% from -$208.2 million recorded in FY2024.
  • Twist Bioscience's 5-year EBT high stood at -$77.0 million for FY2025, and its period low was -$228.3 million during FY2022.
  • Its 3-year average for EBT is -$162.9 million, with a median of -$203.5 million in 2023.
  • Per our database at Business Quant, Twist Bioscience's EBT slumped by 48.20% in 2022 and then spiked by 63.03% in 2025.
  • Yearly analysis of 5 years shows Twist Bioscience's EBT stood at -$154.0 million in 2021, then plummeted by 48.20% to -$228.3 million in 2022, then increased by 10.87% to -$203.5 million in 2023, then decreased by 2.31% to -$208.2 million in 2024, then spiked by 63.03% to -$77.0 million in 2025.